Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Aytu Biopharma Inc AYTU

Healthcare

Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended... see more

Add To Watchlist

Bullboard (NDAQ:AYTU)

View:

Post by Johnthe6on Jun 20, 2024 11:53am

Aytu live streaming

AYTU goes live stream at the conference https://2ly.link/1yXNe

Post by Johnthe6on Jun 17, 2024 1:39pm

aytu new presentation

Aytu BioPharma is going to have a new presentation! It’s free! Free register here: https://buff.ly/4bSLhjm

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Post by Johnthe6on Jun 05, 2024 3:21pm

Aytu biopharma presentation on Jun 20

I saw that Aytu is going to give a talk at this virtual event! And it’s free! https://buff.ly/4bSLhjm

Post by AviseAnalyticson Nov 28, 2023 7:27am

AYTU BIOPHARMA: LEADING THE ADHD DRUG MARKET

$AYTU Excited to share an article about Aytu BioPharma, Inc. (NASDAQ: AYTU), a pharmaceutical company focused on commercializing novel therapeutics. The Company emphasizes ADHD and pediatric ...more

(0)
•••

Post by PressReleaseon Nov 14, 2023 4:17pm

New Press Release - Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

Q1 2024 Adjusted EBITDA of $2.2 millionRx Segment net revenue of $17.8 million and Adjusted EBITDA of $2.4 million in Q1 2024Q1 2024 ADHD net revenue up 31% compared to Q1 2023$20.0 million cash balance at September 30, 2023Company to host conference call today at 4:30pm ETDENVER, CO / ACCESSWIRE...read article.

(0)
•••

Post by PressReleaseon Nov 08, 2023 8:31am

New Press Release - Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

Ranked 118th Fastest Growing Company in North AmericaRanked 23rd Fastest Growing Life Sciences CompanyDENVER, CO / ACCESSWIRE / November 8, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, today announced...read article.

(0)
•••

Post by PressReleaseon Nov 07, 2023 4:17pm

New Press Release - Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

DENVER, CO / ACCESSWIRE / November 7, 2023 / Aytu BioPharma, Inc. (the Company or "Aytu") (NASDAQ:AYTU), a pharmaceutical company focused on commercializing novel therapeutics, will report financial results for its first quarter of fiscal year 2024 for the period ended September 30, 2023, after...read article.

(0)
•••

Post by PressReleaseon Oct 26, 2023 8:02am

New Press Release - Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

U.S. Food & Drug Administration Approval of the Prior Approval Supplement (PAS) Enables Transfer of Cotempla Production to Contract ManufacturerUpon Completion of Manufacturing Transfer of Adzenys XR-ODT and Cotempla XR-ODT, Company Expects to Report Enhanced ADHD Product MarginsDENVER, CO...read article.

Comment by Securecheck1on Oct 20, 2023 8:12pm

RE:RE:RE:RE:Why is this restricted

You got a point there

Discussion

Post by Securecheck1on Oct 18, 2023 7:41pm

Stockhouse sucks

It's real easy to get two accounts on Stockhouse but real hard to cancel one. My other account is Patienceiskee.. and if they don't cancel it I'll open a third one and get just as ...more

Comment by Securecheck1on Oct 18, 2023 7:22pm

RE:RE:RE:RE:Why is this restricted

It's really easy to make two accounts but really hard to cancel on stockhouse. It's like I'm talking to myself LOL

Discussion

Post by Securecheck1on Oct 18, 2023 7:20pm

Hey patiencisky

Hey patience is key. Or whatever. It's really easy to make two accounts on stockhouse BUT really hard to cancel your account isn't it

Post by Securecheck1on Oct 18, 2023 7:06pm

RE:RE:RE:RE:Why is this thing restricted

Another sleazy investor trying to weasel people into his little nest of BBC loving little Susie's

126

Comment by Patienceiskeeon Oct 16, 2023 6:36pm

RE:RE:RE:Why is this restricted

Another sleazy investor trying to weasel people into his little nest of BBC loving little Susie's

Discussion

Comment by Patienceiskeeon Mar 19, 2021 8:20am

RE:RE:Why is this restricted

I picked up 10,000 shares after the reversal. Just an educated guess this will be close to 15 your summer

192

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Bullboard - Stock Discussion Forum Aytu Biopharma Inc AYTU

Bullboard (NDAQ:AYTU)

Aytu live streaming

aytu new presentation

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

Aytu biopharma presentation on Jun 20

AYTU BIOPHARMA: LEADING THE ADHD DRUG MARKET

New Press Release - Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results

New Press Release - Aytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive Year

New Press Release - Aytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023

New Press Release - Aytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval Supplement

RE:RE:RE:RE:Why is this restricted

Stockhouse sucks

RE:RE:RE:RE:Why is this restricted

Hey patiencisky

RE:RE:RE:RE:Why is this thing restricted

RE:RE:RE:Why is this restricted

RE:RE:Why is this restricted

Featured News Links

Discover Options Trading Strategies to Minimize your Tax Burden

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Aytu Biopharma Inc AYTU

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (NDAQ:AYTU)

Featured News Links